Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
Titel:
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
Auteur:
Shadman, Mazyar Flinn, Ian W Levy, Moshe Y Porter, Ryan F Burke, John M Zafar, Syed F Misleh, Jamal Kingsley, Edwin C Yimer, Habte A Freeman, Benjamin Rao, Subramanya S Chaudhry, Arvind Tumula, Praveen K Gandhi, Mitul D Manda, Sudhir Chen, Dih-Yih By, Kunthel Xu, Linlin Liu, Ye Crescenzo, Rocco Idoine, Adam Zhang, Xiaoping Cohen, Aileen Huang, Jane Sharman, Jeff P